These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33315139)

  • 1. [Ophthalmological manifestations of neuronal ceroid lipofuscinoses (NCL) : NCL as diseases of brain and retina-the role of ophthalmologists].
    Atiskova Y; Kohlschütter A; Spitzer MS; Dulz S
    Ophthalmologe; 2021 Feb; 118(2):113-118. PubMed ID: 33315139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostics and treatment of neuronal ceroid lipofuscinoses from the viewpoint of neuropediatricians].
    Steinfeld R
    Ophthalmologe; 2010 Jul; 107(7):616-20. PubMed ID: 20454899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental therapeutic approaches for the treatment of retinal dystrophy in neuronal ceroid lipofuscinosis].
    Bartsch S; Liu J; Bassal M; Jankowiak W; Spitzer MS; Bartsch U
    Ophthalmologe; 2021 Feb; 118(2):106-112. PubMed ID: 33030566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Juvenile neuronal ceroid lipofuscinosis. Ophthalmologic findings and differential diagnosis].
    Krohne TU; Herrmann P; Kopitz J; Rüther K; Holz FG
    Ophthalmologe; 2010 Jul; 107(7):606-11. PubMed ID: 20454901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental Therapeutic Approaches for the Treatment of Retinal Pathology in Neuronal Ceroid Lipofuscinoses.
    Bartsch U; Storch S
    Front Neurol; 2022; 13():866983. PubMed ID: 35509995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NCL diseases - clinical perspectives.
    Schulz A; Kohlschütter A; Mink J; Simonati A; Williams R
    Biochim Biophys Acta; 2013 Nov; 1832(11):1801-6. PubMed ID: 23602993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of the ophthalmologist in the management of juvenile neuronal ceroid lipofuscinosis].
    Rüther K; Gal A; Kohlschütter A
    Klin Monbl Augenheilkd; 2006 Jun; 223(6):542-4. PubMed ID: 16804827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal ceroid lipofuscinosis associated with an MFSD8 mutation in Chihuahuas.
    Ashwini A; D'Angelo A; Yamato O; Giordano C; Cagnotti G; Harcourt-Brown T; Mhlanga-Mutangadura T; Guo J; Johnson GS; Katz ML
    Mol Genet Metab; 2016 Aug; 118(4):326-32. PubMed ID: 27211611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Therapy Approaches to Treat the Neurodegeneration and Visual Failure in Neuronal Ceroid Lipofuscinoses.
    Kleine Holthaus SM; Smith AJ; Mole SE; Ali RR
    Adv Exp Med Biol; 2018; 1074():91-99. PubMed ID: 29721932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of retinal degeneration in ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinoses.
    Murray SJ; Mitchell NL
    Sci Rep; 2022 Mar; 12(1):3670. PubMed ID: 35256654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine neuronal ceroid lipofuscinoses: Promising models for preclinical testing of therapeutic interventions.
    Katz ML; Rustad E; Robinson GO; Whiting REH; Student JT; Coates JR; Narfstrom K
    Neurobiol Dis; 2017 Dec; 108():277-287. PubMed ID: 28860089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal ceroid-lipofuscinoses: the current status.
    Goebel HH
    Brain Dev; 1992 Jul; 14(4):203-11. PubMed ID: 1443397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal ceroid lipofuscinosis: impact of recent genetic advances and expansion of the clinicopathologic spectrum.
    Cotman SL; Karaa A; Staropoli JF; Sims KB
    Curr Neurol Neurosci Rep; 2013 Aug; 13(8):366. PubMed ID: 23775425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile neuronal ceroid lipofuscinosis (JNCL) and the eye.
    Bozorg S; Ramirez-Montealegre D; Chung M; Pearce DA
    Surv Ophthalmol; 2009; 54(4):463-71. PubMed ID: 19539834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards understanding the neuronal ceroid lipofuscinoses.
    Kohlschütter A; Schulz A
    Brain Dev; 2009 Aug; 31(7):499-502. PubMed ID: 19195801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and genetic description of neuronal ceroid lipofuscinosis 6 type in the yakut family].
    Golikova PI; Petukhova DA; Sukhomyasova AL; Nikolaeva TY; Gurinova EE; Ivanova RN; Maksimova NR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(8):71-76. PubMed ID: 34481439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive retinal degeneration and glial activation in the CLN6 (nclf) mouse model of neuronal ceroid lipofuscinosis: a beneficial effect of DHA and curcumin supplementation.
    Mirza M; Volz C; Karlstetter M; Langiu M; Somogyi A; Ruonala MO; Tamm ER; Jägle H; Langmann T
    PLoS One; 2013; 8(10):e75963. PubMed ID: 24124525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving towards a new era of genomics in the neuronal ceroid lipofuscinoses.
    Butz ES; Chandrachud U; Mole SE; Cotman SL
    Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165571. PubMed ID: 31678159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 36 patients from Turkey with neuronal ceroid lipofuscinosis: clinical, neurophysiological, neuroradiological and histopathologic studies.
    Topçu M; Tan H; Yalnizoğlu D; Usubütün A; Saatçi I; Aynaci M; Anlar B; Topaloğlu H; Turanli G; Köse G; Aysun S
    Turk J Pediatr; 2004; 46(1):1-10. PubMed ID: 15074367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in gene and cell therapies for the neuronal ceroid lipofuscinoses.
    Donsante A; Boulis NM
    Expert Opin Biol Ther; 2018 Jul; 18(7):755-764. PubMed ID: 29936867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.